Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Sustained activation of p38 mitogen-activated protein kinase contributes to the vascular response to injury.

Ju H, Nerurkar S, Sauermelch CF, Olzinski AR, Mirabile R, Zimmerman D, Lee JC, Adams J, Sisko J, Berova M, Willette RN.

J Pharmacol Exp Ther. 2002 Apr;301(1):15-20.

PMID:
11907152
2.

Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist.

Aiyar N, Daines RA, Disa J, Chambers PA, Sauermelch CF, Quiniou M, Khandoudi N, Gout B, Douglas SA, Willette RN.

J Pharmacol Exp Ther. 2001 Mar;296(3):768-75.

PMID:
11181905
3.

Human urotensin-II is a potent vasoactive peptide: pharmacological characterization in the rat, mouse, dog and primate.

Douglas SA, Ashton DJ, Sauermelch CF, Coatney RW, Ohlstein DH, Ruffolo MR, Ohlstein EH, Aiyar NV, Willette RN.

J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S163-6.

PMID:
11078367
4.

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.

Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, McNulty DE, Ellis CE, Elshourbagy NA, Shabon U, Trill JJ, Hay DW, Ohlstein EH, Bergsma DJ, Douglas SA.

Nature. 1999 Sep 16;401(6750):282-6. Erratum in: Nature 1999 Dec 23-30;402(6764):898.

PMID:
10499587
5.

Plasma- and cerebrospinal fluid-immunoreactive endothelin-1: effects of nonpeptide endothelin receptor antagonists with diverse affinity profiles for endothelin-A and endothelin-B receptors.

Willette RN, Sauermelch CF, Storer BL, Guiney S, Luengo JI, Xiang JN, Elliott JD, Ohlstein EH.

J Cardiovasc Pharmacol. 1998;31 Suppl 1:S149-57.

PMID:
9595425
6.

Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.

Willette RN, Shiloh AO, Sauermelch CF, Sulpizio A, Michell MP, Cieslinski LB, Torphy TJ, Ohlstein EH.

J Cereb Blood Flow Metab. 1997 Feb;17(2):210-9.

PMID:
9040501
7.

Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog.

Willette RN, Ohlstein EH, Mitchell MP, Sauermelch CF, Beck GR, Luttmann MA, Hay DW.

J Pharmacol Exp Ther. 1997 Feb;280(2):695-701.

PMID:
9023281
8.

Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm.

Willette RN, Zhang H, Mitchell MP, Sauermelch CF, Ohlstein EH, Sulpizio AC.

Stroke. 1994 Dec;25(12):2450-5; discussion 2456.

PMID:
7974589
9.

A comparison of (+)SK&F 10047 and MK-801 on cortical spreading depression.

Willette RN, Lysko PG, Sauermelch CF.

Brain Res. 1994 Jun 20;648(2):347-51.

PMID:
7922552
10.

Transient forebrain ischemia alters acutely endothelin receptor density and immunoreactivity in gerbil brain.

Willette RN, Ohlstein EH, Pullen M, Sauermelch CF, Cohen A, Nambi P.

Life Sci. 1993;52(1):35-40.

PMID:
8417278
11.

Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis.

Willette RN, Sauermelch CF, Rycyna R, Sarkar S, Feuerstein GZ, Nichols AJ, Ohlstein EH.

Stroke. 1992 May;23(5):703-11.

PMID:
1605806
12.

Sympathetic regulation of cutaneous circulation in the rat.

Willette RN, Hieble JP, Sauermelch CF.

J Auton Nerv Syst. 1991 Feb;32(2):135-44.

PMID:
1851506
13.

The role of alpha adrenoceptor subtypes in sympathetic control of the acral-cutaneous microcirculation.

Willette RN, Hieble JP, Sauermelch CF.

J Pharmacol Exp Ther. 1991 Feb;256(2):599-605.

PMID:
1847204
14.

Abluminal effects of endothelin in cerebral microvasculature assessed by laser-Doppler flowmetry.

Willette RN, Sauermelch CF.

Am J Physiol. 1990 Dec;259(6 Pt 2):H1688-93.

PMID:
2124424
15.

Local cutaneous hemodynamic effects of carvedilol and labetalol in the anesthetized rat.

Willette RN, Sauermelch CF, Ruffolo RR Jr.

Eur J Pharmacol. 1990 Feb 6;176(2):237-40.

PMID:
2311669
16.

Role of alpha-1 and alpha-2 adrenoceptors in the sympathetic control of the proximal urethra.

Willette RN, Sauermelch CF, Hieble JP.

J Pharmacol Exp Ther. 1990 Feb;252(2):706-10.

PMID:
2156058
17.

Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation.

Ruffolo RR Jr, Sauermelch CF, Willette RN.

Eur J Clin Pharmacol. 1990;38 Suppl 2:S112-4.

PMID:
1974499

Supplemental Content

Loading ...
Support Center